| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Friday’s Close |
|---|---|---|---|---|---|
| BIIB | Biogen Inc. | $296.86 | $62.64B | Uptrend |
Better Buy: Biogen Inc. vs. Celgene
https://www.fool.com/investing/2018/06/03/better-buy-biogen-inc-vs-celgene.aspx?source=iedfolrf0000001
Jun 03, 2018 - Which of these beaten-down biotech stocks wins in a head-to-head match-up?
1
BIIB: Canaccord Genuity ups to Buy
http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180531095132
May 31, 2018 - Canaccord Genuity issues rating change for BIIB
0
Why is Biogen (BIIB) Up 6.7% Since Its Last Earnings Report?
http://www.zacks.com/stock/news/304840/why-is-biogen-biib-up-67-since-its-last-earnings-report?cid=CS-ZC-FT-304840
May 24, 2018 - Biogen (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Better Buy: Acadia Pharmaceuticals vs. Biogen
https://www.fool.com/investing/2018/05/18/better-buy-acadia-pharmaceuticals-vs-biogen.aspx?source=iedfolrf0000001
May 18, 2018 - Which of these beaten-down biotech stocks is in better position to mount a strong comeback?
0
Should You Invest in the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)?
http://www.zacks.com/stock/news/303984/should-you-invest-in-the-powershares-dynamic-biotechnology-genome-portfolio-pbe?cid=CS-ZC-FT-303984
May 17, 2018 - Sector ETF report for PBE
0
Sangamo Therapeutics Stock History
https://www.fool.com/investing/2018/05/17/sangamo-therapeutics-stock-history.aspx?source=iedfolrf0000001
May 17, 2018 - After decades of research into gene editing, this biotech company could be on the cusp of developing game-changing new treatments for rare diseases.
0
Better Buy: Amgen Inc. vs. Biogen Inc.
https://www.fool.com/investing/2018/05/15/better-buy-amgen-inc-vs-biogen.aspx?source=iedfolrf0000001
May 15, 2018 - Find out which biotech stock stands tallest after a head-to-head matchup.
0
Novartis Multiple Sclerosis Drug Gets FDA Nod for Adolescents
http://www.zacks.com/stock/news/303439/novartis-multiple-sclerosis-drug-gets-fda-nod-for-adolescents?cid=CS-ZC-FT-303439
May 14, 2018 - The FDA approves Novartis' (NVS) multiple sclerosis drug Gilenya for the treatment of children and adolescents aged between 10 and 18.
0
Ionis Pharmaceuticals Prepares for Launch
https://www.fool.com/investing/2018/05/09/ionis-pharmaceuticals-prepares-for-launch.aspx?source=iedfolrf0000001
May 09, 2018 - The biotech has the potential for two FDA approvals this year.
0
3 Stocks That Turned $10,000 Into $1 Million
https://www.fool.com/investing/2018/05/09/3-stocks-that-turned-10000-into-1-million.aspx?source=iedfolrf0000001
May 09, 2018 - These three biotech stocks delivered monster returns over the past couple of decades. Here's how.
0
Page 1>